VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

January 31, 2008

Conditions
Multiple Myeloma
Interventions
DRUG

Velcade/Dexamethasone

Velcade 1,3 mg/m2 on days 1, 4, 8 and 11

Trial Locations (10)

Unknown

Hospital Clínic, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Germans Trias i Pujol, Barcelona

Hospital Clínico San Carlos de Madrid, Madrid

Hospital Doce de Octubre, Madrid

Hospital Universitario de la Princesa, Madrid

Clínica Universitaria de Navarra, Pamplona

Hospital La Fe, Valencia

Hospital Universitario de Salamanca, Salamanca

Hospital General de Segovia, Segovia

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00391157 - VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma | Biotech Hunter | Biotech Hunter